Postmenopausal osteoporosis

Exam relevance: in 4 of more than 150 board exam reports · rank 111

Synonyms
osteoporosis, bone loss
Specialty
Gynaecology · Endocrinology & cycle
Images
Mammography/MRI 1 · Diagram 1
Exam relevance
4 of more than 150 reports · rank 111
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (2)
  2. Definition
  3. Classification
  4. Occurrence & epidemiology
  5. Aetiopathogenesis
  6. Clinical features
  7. Diagnosis
  8. Treatment principles
  9. Keep learning in the app
  10. Further reading (selection)
  11. Cross-references

Images (2)

Postmenopausal osteoporosis – CT (thoracic spine, axial and sagittal): severe osteoporosis in an 85-year-old woman – rarefied cancellous bone with accentuated vertical trabeculae and insufficiency fractures with …Mammography/MRI
CT (thoracic spine, axial and sagittal): severe osteoporosis in an 85-year-old woman – rarefied cancellous bone with accentuated vertical trabeculae and insufficiency fractures with …Image: Hellerhoff (Wikimedia Commons) · CC BY-SA 4.0 · Source
Postmenopausal osteoporosis – diagram: Diagram: osteoporotic cancellous bone – thinned, partly disrupted trabeculae with enlarged marrow spacesDiagram
Diagram: osteoporotic cancellous bone – thinned, partly disrupted trabeculae with enlarged marrow spacesImage: Laboratoires Servier, “Rheumatology - Osteoporotic bone -- Smart-Servier” (Wikimedia Commons) · CC BY-SA 3.0 · Source
1 / 2

Definition

  • Osteoporosis is a systemic skeletal disease with low bone mass and distorted microarchitecture, leading to increased fracture susceptibility; in the postmenopausal form, oestrogen deficiency predominates.
  • According to the WHO, osteoporosis is present at a DXA T-score of −2.5 SD or lower; severe (established) osteoporosis additionally requires at least one fragility fracture.

Classification

  • Primary postmenopausal (type I) osteoporosis is due to oestrogen deficiency; senile (type II) osteoporosis is mainly age-related and affects women about twice as often as men.
  • Secondary osteoporosis due to other underlying diseases or substances accounts for up to 30% of osteoporosis in postmenopausal women.

Occurrence & epidemiology

Epidemiology

  • Most cases of osteoporosis occur in postmenopausal women and older men; peak bone mass is reached around the age of 30.

Aetiopathogenesis

Aetiology and pathogenesis

  • With menopause, bone loss accelerates to about 2% per year for about 10 years; trabecular bone is lost faster than cortical bone because of its higher turnover.
  • Risk factors include older age, a positive family history especially of parental hip fracture, low body mass index, immobilisation, smoking, alcohol and insufficient calcium or vitamin D intake.

Clinical features

  • The disease is asymptomatic until a fracture occurs; vertebral compression fractures are the most common osteoporotic fractures, but about two-thirds of them remain asymptomatic.
  • Typical fracture sites are the thoracic and lumbar spine, femoral neck and distal radius; multiple vertebral fractures lead to height loss and kyphosis.

Diagnosis

  • Bone mineral density is measured by DXA, usually at the spine and hip; if these sites are unsuitable, the distal radius (1/3 radius) is used.
  • Regardless of bone mineral density, osteoporosis can also be diagnosed on the basis of a fragility fracture, particularly of the spine, hip, humerus or distal radius.
  • Secondary causes are sought with calcium, phosphate, 25-hydroxyvitamin D, liver tests including alkaline phosphatase, parathyroid hormone and 24-hour urine calcium and creatinine, supplemented by TSH and blood count depending on the clinical picture.

Treatment principles

  • The foundation consists of basic measures such as physical activity, a balanced diet, fall prevention and review of medicines that harm bone.
  • Drug treatment is started according to the individual fracture risk, usually with antiresorptive drug classes such as bisphosphonates, RANKL antibodies or selective oestrogen receptor modulators.
  • In very high fracture risk, first-line bone-forming (osteoanabolic) therapy is considered, as it was superior to antiresorptive drugs in comparative trials; menopausal hormone therapy is an option mainly in younger postmenopausal women, particularly those with climacteric symptoms.

Specific treatment regimens with drugs and doses are covered in the GynFuchs app.

Keep learning in the app

In the GynFuchs app you can learn Postmenopausal osteoporosis with flashcards, exam questions and image tasks (colposcopy, ultrasound, CTG) – free, in your browser or as an app.

Open in browser  About GynFuchs →

Further reading (selection)

  1. MSD Manual Professional: Osteoporosis
  2. Educational Case: Osteoporosis
  3. Beyond the T-Score: A Narrative Clinical Review of Adult Endocrine Osteoporosis Care

Cross-references

Keep learning

Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.

Related pages: Premature ovarian insufficiency (POI) · Premenstrual syndrome (PMS/PMDD) · Precocious and delayed puberty

Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.